A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial
John Farley, William E. Brady, David M. O’Malley, Keiichi Fujiwara, Kan Yonemori, Albert J. Bonebrake, Angeles Alvarez Secord, Jean-Marie Stéphan, Joan L. Walker, Joo‐Hyun Nam, Michael J. Birrer, David M. Gershenson
Topics & Concepts
TemsirolimusMedicineCarboplatinInternal medicineRegimenNeutropeniaOncologyLeukopeniaProgression-free survivalChemotherapyChemistryBiochemistryProtein kinase BCisplatinDiscovery and development of mTOR inhibitorsApoptosisOvarian cancer diagnosis and treatmentLung Cancer Research StudiesPARP inhibition in cancer therapy